Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
0.4251
+0.0271 (6.81%)
At close: Jun 10, 2025, 4:00 PM
0.4284
+0.0033 (0.78%)
After-hours: Jun 10, 2025, 7:48 PM EDT
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $28.50 million as of June 10, 2025. Its market cap has decreased by -86.32% in one year.
Market Cap
28.50M
Enterprise Value
-41.83M
1-Year Change
-86.32%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $28.50M, a decrease of -97.34%. That is a compound annual growth rate of -51.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2025 | 28.50M | -59.75% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.64B |
| Johnson & Johnson | 376.43B |
| Novo Nordisk | 353.20B |
| AbbVie | 334.73B |
| UnitedHealth Group | 275.58B |
| Abbott Laboratories | 233.36B |
| Novartis AG | 232.35B |
| AstraZeneca | 227.75B |